BIANCO, Andrea
 Distribuzione geografica
Continente #
EU - Europa 12.856
NA - Nord America 6.667
AS - Asia 5.892
SA - Sud America 937
AF - Africa 69
OC - Oceania 12
Continente sconosciuto - Info sul continente non disponibili 6
Totale 26.439
Nazione #
RU - Federazione Russa 8.576
US - Stati Uniti d'America 6.559
SG - Singapore 1.906
IE - Irlanda 1.349
HK - Hong Kong 1.149
CN - Cina 1.137
VN - Vietnam 897
IT - Italia 877
BR - Brasile 782
GB - Regno Unito 486
UA - Ucraina 458
DE - Germania 431
KR - Corea 297
GR - Grecia 157
FI - Finlandia 148
IN - India 119
FR - Francia 109
TR - Turchia 80
SE - Svezia 77
JP - Giappone 72
AR - Argentina 67
BD - Bangladesh 46
CA - Canada 41
AT - Austria 40
MX - Messico 38
BE - Belgio 36
EC - Ecuador 28
NL - Olanda 27
IQ - Iraq 25
ID - Indonesia 23
UZ - Uzbekistan 19
CH - Svizzera 17
PY - Paraguay 15
ZA - Sudafrica 15
PL - Polonia 14
MA - Marocco 13
CL - Cile 12
ES - Italia 12
IL - Israele 12
PH - Filippine 12
VE - Venezuela 12
AU - Australia 11
PK - Pakistan 11
CO - Colombia 10
AL - Albania 9
BJ - Benin 9
JM - Giamaica 9
SA - Arabia Saudita 9
AE - Emirati Arabi Uniti 8
EG - Egitto 8
KE - Kenya 7
PT - Portogallo 7
TW - Taiwan 7
AZ - Azerbaigian 6
EU - Europa 6
IR - Iran 6
JO - Giordania 6
NP - Nepal 6
TN - Tunisia 6
CZ - Repubblica Ceca 5
DO - Repubblica Dominicana 5
KZ - Kazakistan 5
MK - Macedonia 5
MY - Malesia 5
PE - Perù 5
UY - Uruguay 5
LT - Lituania 4
CR - Costa Rica 3
GE - Georgia 3
HN - Honduras 3
KG - Kirghizistan 3
OM - Oman 3
PA - Panama 3
PS - Palestinian Territory 3
TT - Trinidad e Tobago 3
BG - Bulgaria 2
BH - Bahrain 2
ET - Etiopia 2
LB - Libano 2
LV - Lettonia 2
MD - Moldavia 2
MN - Mongolia 2
MU - Mauritius 2
QA - Qatar 2
SV - El Salvador 2
SY - Repubblica araba siriana 2
TH - Thailandia 2
AF - Afghanistan, Repubblica islamica di 1
AM - Armenia 1
AO - Angola 1
BO - Bolivia 1
BW - Botswana 1
BY - Bielorussia 1
CG - Congo 1
CY - Cipro 1
DZ - Algeria 1
EE - Estonia 1
HU - Ungheria 1
KW - Kuwait 1
LA - Repubblica Popolare Democratica del Laos 1
Totale 26.431
Città #
Moscow 3.042
Dublin 1.348
Hong Kong 1.120
Santa Clara 913
San Jose 909
Jacksonville 809
Chandler 762
Singapore 749
Seoul 292
Ashburn 288
Ho Chi Minh City 262
Beijing 235
Hanoi 213
The Dalles 190
Princeton 188
Hefei 170
Roxbury 163
Dallas 136
Medford 124
Naples 124
Bremen 123
Los Angeles 105
Munich 81
Nuremberg 81
Caserta 80
New York 73
Bengaluru 71
Cambridge 68
Da Nang 66
Wilmington 65
Des Moines 64
Ann Arbor 62
São Paulo 62
Boardman 61
Helsinki 53
Haiphong 50
Brussels 36
Rome 34
San Mateo 33
Woodbridge 33
Aversa 31
Frankfurt am Main 29
Milan 27
Orem 27
Rio de Janeiro 26
Council Bluffs 25
Napoli 25
Atlanta 21
Belo Horizonte 19
Hải Dương 19
Orta di Atella 19
Shanghai 19
Dong Ket 18
Guangzhou 18
Jinan 18
Tashkent 18
Tokyo 18
Amsterdam 17
Memphis 17
Chennai 16
Vienna 16
Chicago 15
Mountain View 15
Brasília 14
Bắc Ninh 14
Columbus 14
Norwalk 14
San Giuseppe Vesuviano 14
Thái Bình 14
Curitiba 13
Nanjing 13
Biên Hòa 12
Bến Tre 12
Ercolano 12
Guayaquil 12
Montreal 12
San Francisco 12
Baghdad 11
Kunming 11
Mexico City 11
New Delhi 11
Ninh Bình 11
Tianjin 11
Warsaw 11
Can Tho 10
Guarulhos 10
Jakarta 10
Porto Alegre 10
Thái Nguyên 10
Turku 10
Arzano 9
Houston 9
Istanbul 9
Manchester 9
Seattle 9
Shenzhen 9
Boston 8
Como 8
Da Lat 8
Düsseldorf 8
Totale 14.216
Nome #
" Gemcitabine + Vinorelbine (GV) Vs Gemcitabine + Paclitaxel (GT) Vs Gemcitabine (G) Vs Paclitaxel (P) in elderly NSCLC patients". 231
Adiponectin down-regulates CREB and inhibits proliferation of A549 lung cancer cells 212
Anticoagulant treatment in COVID-19: a narrative review 208
Diagnostic issues faced by a rare disease healthcare network during Covid-19 outbreak: data from the Campania Rare Disease Registry 205
Application and internal validation of lung ultrasound score in COVID-19 setting: The ECOVITA observational study 197
Adiponectin affects lung epithelial A549 cell viability counteracting TNFa and IL-1ß toxicity through AdipoR1 188
Comorbidities in COPD: Current and Future Treatment Challenges 182
Adiponectin in asthma: Implications for phenotyping 182
Adiponectin is involved in the control of human lung epithelial A549 cell viability 179
Adiponectin: An attractive marker for metabolic disorders in chronic obstructive pulmonary disease (COPD) 178
Evolving concepts in COPDand lung cancer: a narrative review 174
T lymphocyte phenotypic profile in lung segments affected by cavitary and non-cavitary tuberculosis 173
Adiponectin is Associated with Neutrophils to Lymphocyte Ratio in Patients with Chronic Obstructive Pulmonary Disease 173
Adiponectin Increase in Patients Affected by Chronic Obstructive Pulmonary Disease with Overlap of Bronchiectasis 172
Integrated therapeutic approach to giant solitary fibrous tumor of the pleura: Report of a case and review of the literature 170
Adiponectin oligomerization state and adiponectin receptors airway expression in chronic obstructive pulmonary disease 169
Adiponectin, Leptin, and Resistin Are Dysregulated in Patients Infected by SARS-CoV-2 168
Descending necrotizing mediastinitis in the elderly patients 166
ACE2: The Major Cell Entry Receptor for SARS-CoV-2 162
Adiponectin and leptin exert antagonizing effects on huvec tube formation and migration modulating the expression of cxcl1, vegf, mmp‐2 and mmp‐9 161
Aberrant expression of BARD1 in breast and ovarian cancers with poor prognosis 160
Adiponectin as Link Factor between Adipose Tissue and Cancer 160
Adjuvant treatment with EGFR TKI in resected non-small cell lung cancer with EGFR mutation: all that glitters is not gold! 159
Aspetti anatomo clinici delle malattie respiratorie 158
Adiponectin and its isoforms are overexpressed in COPD patients 158
Asma Bronchiale (recenti acquisizioni sperimentali e contributi personali) 154
Severe respiratory SARS-CoV2 infection: Does ACE2 receptor matter? 154
Relevance of lung ultrasound in the diagnostic algorithm of respiratory diseases in a real-life setting: A multicentre prospective study 151
Effectiveness of home-based preoperative pulmonary rehabilitation in COPD patients undergoing lung cancer resection 151
Effects of Different Corticosteroid Doses in Elderly Unvaccinated Patients with Severe to Critical COVID-19 151
Clinical characteristics, exercise capacity and pulmonary function in post-covid-19 competitive athletes 150
A chest wall problem. 150
Preoperative high-intensity training in frail old patients undergoing pulmonary resection for NSCLC 150
Cardiovascular system in COVID-19: Simply a viewer or a leading actor? 150
Malattie dell'apparato respiratorio 149
Multidisciplinary Approach to the Diagnosis of Idiopathic Interstitial Pneumonias: Focus on the Pathologist’s Key Role 149
Exposure to Submicron Particles (PM1.0) from Diesel Exhaust and Pollen Allergens of Human Lung Epithelial Cells Induces Morphological Changes of Mitochondria Tonifilaments and Rough Endoplasmic Reticulum 149
Exploring the Role of Krebs von den Lungen-6 in Severe to Critical COVID-19 Patients 145
EXPLORING THE ROLE OF KREBS VON DEN LUNGEN-6 (KL-6) IN SEVERE TO CRITICAL COVID-19: A SINGLE INSTITUTION EXPERIENCE 145
RFA of primary and metastatic lung tumors: long-term results 145
Sirtuins and Cellular Senescence in Patients with Idiopathic Pulmonary Fibrosis and Systemic Autoimmune Disorders 144
A biological model to explain the association between human rhinovirus respiratory infections and bronchial asthma 144
Complete response to pembrolizumab as a single agent in a patient with stage III NSCLC with high PD-L1 expression: a case report 143
Which impact for proton pump inhibitors in SARS-CoV-2 pneumonia 142
Spirometry in elderly laryngectomized patients: A feasibility study 142
B-flow twinkling sign in preoperative evaluation of cervical lymph nodes in patients with papillary thyroid carcinoma. 141
Idiopathic pulmonary fibrosis and lung cancer: targeting the complexity of the pharmacological interconnection 140
Cardiovascular prosthetic surgery: an analysis of cellular and molecular patterns underlying valve implantation failure. 140
Effects of diesel exhaust particles on human lung epithelial cells: an in vitro study 139
Benefi ts of Pulmonary Rehabilitation in Idiopathic Pulmonary Fibrosis 137
Lung and Nodal Involvement in Nontuberculous Mycobacterial Disease: PET/CT Role 137
Benefits of Pulmonary Rehabilitation in Idiopathic Pulmonary Fibrosis: A CASE REPORT 136
Routine invasive mediastinal staging of lung cancer in elderly patients without lymph adenopathy on pet-ct scan: Is an appropriate choice? 133
Strategies Tackling Viral Replication and Inflammatory Pathways as Early Pharmacological Treatment for SARS-CoV-2 Infection: Any Potential Role for Ketoprofen Lysine Salt? 132
Morphology changes in human lung epithelial cells after exposure to diesel exhaust micron sub particles (PM 1.0) and pollen allergens 132
Ruolo dei fattori di crescita nella induzione della proliferazione fibroblastica nella patogenesi della fibrosi polmonare idiopatica 132
I Farmaci Antiangiogenetici nel Trattamento del Tumore del Polmone 132
Effects of a high-intensity pulmonary rehabilitation program on the minute ventilation/carbon dioxide output slope during exercise in a cohort of patients with COPD undergoing lung resection for non-small cell lung cancer 132
Food, nutrition, physical activity and microbiota: Which impact on lung cancer? 131
Altered peptide ligands change T cell repertoire expression in ParJ 1 specific cell lines 130
The anti-proliferative effects of adiponectin on human lung adenocarcinoma A549 cells and oxidative stress involvement 130
Lung Microbiome as a Treatable Trait in Chronic Respiratory Disorders 128
Diagnostic Accuracy of Ultrasound Guided Percutaneous Pleural Needle Biopsy for Malignant Pleural Mesothelioma 127
Non-small cell lung cancer presenting as "psoas muscle syndrome": A case report 127
Effetto antinfiammatorio del sodio nedocromile in pazienti asmatici atopici 126
Protective effects of nedocromil sodium on cellular and biohumoral components present in the bronchial alveolar lavage fluid and in peripheral blood in atopic asthmatics 126
Differentially expressed and activated proteins associated with non small cell lung cancer tissues 125
Gemcitabine, ifosfamide and paclitaxel in advanced/metastatic non-small cell lung cancer patients: a phase II study. 125
BARD1: An independent predictor of survival in non-small cell lung cancer 125
Interferon-gamma downregulates the rhinovirus induced expression of intercellular adhesion molecule-1 (ICAM-1) on human airway epithelial cells 125
Potential role of SIRT-1 and SIRT-3 as biomarkers for the diagnosis and prognosis of idiopathic pulmonary fibrosis 122
Potential mechanisms linking atherosclerosis and increased cardiovascular risk in COPD: Focus on sirtuins 122
New insight into adiponectin role in obesity and obesity-related diseases 121
COPD and metabolic disorders: role of adiponectin 121
Disturbi neuropsicologici correlate alla BPCO 121
Raw Bioelectrical Impedance Analysis Variables Are Independent Predictors of Early All-Cause Mortality in Patients With COPD 120
Immune checkpoint inhibitors: a new landscape for extensive stage small cell lung cancer treatment 119
Fractional exhaled nitric oxide-measuring devices: Technology update 117
Inflammatory effects on human lung epithelial cells after exposure to diesel exhaust micron sub particles (PM₁.₀) and pollen allergens. 116
IFNY TRIGGERS APOPTOSIS IN VITRO M.T. ACTIVATED ALVEOLAR MACROPHAGES 116
Anti-inflammatory effects of adiponectin in A549 cells exposed to TNF alpha and IL-1 beta 116
Somatostatin-Dependent Regulation of Alveolar Macrophages Activation and Cytokine Production 116
Frailty in Patients With Lung Cancer: A Systematic Review and Meta-Analysis 115
CORRELATION BETWEEN CHEMICAL MEDIATORS AND HAEMORHEOLOGICAL - COAGULATIVE FACTORS IN THE PATHOGENESIS OF CHRONIC RESPIRATORY FAIL¬URE CAUSED BY INTERSTITIAL LUNG DISEASES (F.I.D) 115
Endoscopic treatment of endobronchial carcinoid: technical considerations and experience in interventional pulmonology 114
Ketoprofen Lysine Salt Versus Corticosteroids in Early Outpatient Management of Mild and Moderate COVID-19: A Retrospective Study 114
Genomic Profiling for Predictive Treatment Strategies in Fibrotic Interstitial Lung Disease 113
Case report: Selpercatinib in the treatment of RET fusion-positive advanced lung adenocarcinoma: a challenging clinical case 113
Targeting Progression in Pulmonary Fibrosis: An Overview of Underlying Mechanisms, Molecular Biomarkers, and Therapeutic Intervention 113
Distinct BARD1 isoforms expressed in lung cancer potential targets for treatment 113
Effectiveness and safety in radiofrequency ablation of pulmonary metastases from HCC: a five years study 113
Regimi di chemioterapia senza derivati del platino in pazienti con neoplasia polmonare non a piccole cellule (NSCLC) avanzata/metastatica (stadio IIIB/IV): efficacia dell’associazione Gemcitabina, Ifosamide, Paclitaxel (GIT). 112
La chemioterapia sequenziale nel trattamento del cancro del polmone non a piccole cellule (NSCLC) in operabile 112
Anti-inflammatory effect of sodium nedocromil in atopic asthmatic patients|EFFETTO ANTIINFIAMMATORIO DEL SODIO NEDOCROMILE IN PAZIENTI ASMATICI ATOPICI 111
Mechanisms and Clinical Implications of Endothelial Dysfunction in Arterial Hypertension 111
High-Flow Nasal Cannula System in Respiratory Failure Associated with Interstitial Lung Diseases: A Systematic Review and Narrative Synthesis 111
Pharmacological Treatment of Interstitial Lung Diseases: A Novel Landscape for Inhaled Agents 111
The burden of obesity in asthma and COPD: Role of adiponectin 111
Clinical impact of nasal budesonide treatment on COPD patients with coexistent rhinitis 110
Rilevazione di ECP, Triptasi ed IgE totali nel siero e nel BAL di soggetti asmatici atopici 109
Totale 14.139
Categoria #
all - tutte 90.425
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 90.425


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202147 0 0 0 0 0 0 0 0 0 0 0 47
2021/20221.123 45 16 10 14 380 14 25 29 60 50 79 401
2022/20232.778 233 52 19 251 320 245 46 179 1.293 29 57 54
2023/20241.132 91 36 61 86 365 67 19 23 16 33 154 181
2024/20254.235 27 83 32 105 626 591 644 343 544 622 392 226
2025/202614.785 517 608 759 675 1.174 7.872 1.145 765 674 284 223 89
Totale 26.900